symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
NYXH,6.705,0.56461,3151,192259170,0,4.36-10.34,0.035,Nyxoah S.A.,USD,0001857190,BE0974358906,,NASDAQ Global Market,NASDAQ,Medical Instruments & Supplies,https://www.nyxoah.com,"Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.",Mr. Olivier  Taelman,Healthcare,BE,137,32 1 022 23 55,Rue Edouard Belin 12,Mont-Saint-Guibert,,1435,,0,https://financialmodelingprep.com/image-stock/NYXH.png,2021-04-28,False,False,True,False,False
